<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01812356</url>
  </required_header>
  <id_info>
    <org_study_id>2012-11-088</org_study_id>
    <nct_id>NCT01812356</nct_id>
  </id_info>
  <brief_title>The Concomitant Cryomaze Procedure Using Nitreous Oxide Cryoprobe: Comparison With Argon Based Cryoprobe</brief_title>
  <official_title>Study of Cryomaze Procedure Using Nitrous Oxide Versus Argon Gas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is compare the surgical convenience and early and long-term outcomes of
      cryomaze procedure using nitrous oxide with using Argon gas.

      The investigators will analyze the pathologic findings of atrial tissue after cryoablation
      using two probes and early and long-term outcomes with Holter monitoring. Atrial fibrillation
      burden 3 months and 1 year postoperatively and atrial activity will be checked.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators have used the Medtronic ATS cryoprobe (Argon based) since 2009 for cryomaze
      procedure for treatment of atrial fibrillation combined with valvular heart disease.

      However, sometimes, it was inconvenient due to excess flexibility, wide lesion related to
      excess low temperature and time-consuming detachment from atrium after cryoablation. The
      investigators introduced Atricure cryoprobe (Nitreos Oxide based) in hope of overcoming these
      shortcomings of ATS probes last year.

      Up to date, the investigators have been satisfactory in terms of the surgical convenience. On
      the other hand, we have the questionability of transmural lesion of Atricure probe because of
      the higher temperature of Atricure probe compared with ATS probe.

      The aim of this study is compare the surgical convenience and early and long-term outcomes of
      cryomaze procedure using nitrous oxide with using Argon gas.

      The investigators will analyze the pathologic findings of atrial tissue after cryoablation
      using two probes and early and long-term outcomes with Holter monitoring. Atrial fibrillation
      burden 3 months and 1 year postoperatively and atrial activity will be checked.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence of atrial fibrillation</measure>
    <time_frame>one year</time_frame>
    <description>Treatment failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative stroke</measure>
    <time_frame>one year</time_frame>
    <description>Thromboembolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial arrhythmia events</measure>
    <time_frame>one year</time_frame>
    <description>AF recurrence, the need for antiarrhythmic drugs for symptoms, permanent pacemaker insertion, and the need for cardioversion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac related death</measure>
    <time_frame>one year</time_frame>
    <description>Including sudden death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart failure</measure>
    <time_frame>one year</time_frame>
    <description>heart failure requiring admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation</measure>
    <time_frame>one year</time_frame>
    <description>reoperation due to heart problems</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intracranial hemorrhage</measure>
    <time_frame>one year</time_frame>
    <description>bleeding complication involving brain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Valve</condition>
  <arm_group>
    <arm_group_label>Argon gas probe</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cryomaze procedure using Argon gas probe</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nitrous oxide probe</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cryomaze procedure using Nitrous oxide probe</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryomaze procedure using Nitrous oxide</intervention_name>
    <description>Cryomaze procedure using Nitrous oxide</description>
    <arm_group_label>Nitrous oxide probe</arm_group_label>
    <other_name>Atricure cryoprobe</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryomaze procedure using Argon</intervention_name>
    <description>Cryomaze procedure using Argon</description>
    <arm_group_label>Argon gas probe</arm_group_label>
    <other_name>ATS medtronic probe</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  requiring concomitant maze operation with valve surgery (persistent atrial
             fibrillation)

          -  between 18 and 75 years old

        Exclusion Criteria:

          -  previous cardiac surgery

          -  Behcet disease

          -  Takayasu's arteritis

          -  Infective endocarditis

          -  Congenital heart disease

          -  left atrial size over 80mm

          -  moderate or greater functional tricuspid regurgitation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pyo Won Park, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2013</study_first_submitted>
  <study_first_submitted_qc>March 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2013</study_first_posted>
  <last_update_submitted>August 22, 2017</last_update_submitted>
  <last_update_submitted_qc>August 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>maze operation</keyword>
  <keyword>cryoablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

